SHBK International Holding Group

SHBK International Holding Group is a diversified investment conglomerate based in the United Arab Emirates, founded and chaired by His Highness Sheikh Hamdan bin Khalifa Al Nahyan. The group maintains a significant presence in the healthcare and biotechnology sectors through its specialized division, SHBK Healthcare, which focuses on regenerative medicine and advanced diagnostics. A key pillar of their life sciences strategy is the development and implementation of stem cell therapies and the distribution of innovative medical devices across the GCC region. SHBK often serves as a strategic gateway for international pharmaceutical and biotech companies looking to establish a commercial or research presence in the Middle East. The company played a notable role in regional pandemic response efforts by facilitating diagnostic testing and vaccine-related infrastructure.